Oncology Flashcards

(48 cards)

1
Q

Management of malignant hypercalcaemia

A

IV 0.9% saline (4-6L, 200-300ml/hr)

Single dose IV bisphosphonates (Zoledronic acid and pamidronate)

IM/SC calcitonin (works quickly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Causes of malignant hypercalcaemia?

A

Osteolysis (lytic bone metastases)

Humoral (PTHrP in breast cancer or squamous cell lung carcinoma)

Dehydration

Tumour specific mechanisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Presentation of malignant hypercalcaemia

A

Bones, stone, groans and psychic moans

GI: abdo pain, constipation, vomiting, weight loss
Renal: stones, polyuria, polydipsia
Neuro: fatigue, weakness, confusion
Psych: depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Management of malignant spinal cord compression

A

Corticosteroids

Surgical decompression

Radiotherapy (for pain control or if unsuitable for surgery)

Chemotherapy (if chemosensitive tumours)

Hormone deprivation (for newly diagnosed prostate cancer)

Analgesia

VTE prophylaxis and pressure sore prevention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Presentation of SCC

A
Worsening back pain 
Leg weakness
Sensory loss below level of lesion 
Bladder and bowel dysfunction (LATE)
Radicular pain 

LMN signs at level of lesion, UMN below level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

SVC obstruction investigations

A

Clinical
CXR (widened mediastinum or mass on right side of heart)
CT scan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Presentation of SVCO

A
Facial, neck, arm and torso oedema 
Dyspnoea, cough, chest pain at rest
Dilated veins in arms and neck and chest wall
Syncope 
Cyanosis 
Severe respiratory distress
Engorged conjunctiva 
Convulsions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Management of SVCO

A
High dose steroids 
Stenting 
Raise head, give oxygen 
Chemo 
Radiotherapy 
Anticoagulation if central vein thrombosis present
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the SIRS criteria?

A
HR >90
RR >20
BP systolic <90
Urine output less than 0.5-1ml/kg/hr
Temp >38 or <36
Acute confusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When would you get a patient with neutropenic sepsis reviewed by a senior clinician

A

Lactate >2
Evidence of end-organ failure
Haemodynamic instability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Abx treatment of patients with neutropenic sepsis

A

Piperacillin with tazobactam (Tazocin) +/- gentamycin

Switch to oral if improving after 24-48 hours

Consider 2nd line (e.g. meropenem) if no improvement after 48 hours

Consider other cause e.g. fungal (candida) or virus if no improvement after 5 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do you prevent neutropenic sepsis in high risk patients

A

Fluoroquinolones e.g. ciprofloxacin

G-CSF (granulocyte colony-stimulating factor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What two criteria are required for diagnosis of neutropenic sepsis

A

> 38 fever

<0.5-1 x 10^9/L neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Most common causative organisms for neutropenic sepsis

A

Staph epidermidis (gram negative, coagulase negative)

Pseudomonas aeruginosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Most common viral causes of neutropenic sepsis

A
Herpes zoster 
Varicella zoster 
Epstein-Barr 
HSV 
Cytomegalovirus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Acquired causes of neutropenia?

A
Drugs (e.g. carbimazole or chemotherapy)
Infection 
Bone marrow disease 
Autoimmune disease 
Nutritional deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Genetic cause of neutropenia

A

Chediak-Higashi syndrome (autosomal recessive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Red flags for back pain

A
Recent infection 
<20 or >55 onset 
Thoracic pain 
Immunocompromise 
History of malignancy 
Fevers, chills, unexplained weight loss 
Night back pain, no better when supine 
IV drug use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Cauda equina presentation

A
LMN signs and symptoms 
Painless urinary retention and overflow incontinence 
Saddle anaesthesia 
Radicular and lower back pain 
Reduced anal tone
Impotence 
Absent ankle jerk 
Asymmetrical weakness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Most common anatomical region of spinal cord to be affected by malignant spinal cord compression

21
Q

Gold standard investigation for spinal cord compression

A

MRI whole spine

22
Q

Most common malignancies to cause malignant spinal cord compression

A
Breast 
Prostate 
Multiple myeloma 
lymphoma 
Lung cancer
23
Q

What collaterals might circumvent a SVCO

A

Azygous
Internal mammary
Long thoracic (femoral and vertebral)

24
Q

Most common cause of SVCO

A

Non-Hodgkin lymphoma

Non-small cell lung carcinoma

25
What is Pemberton's sign?
Raise arms for 1-2 minutes | Increased facial plethora, dilated veins and respiratory distress
26
Investigation of choice for SVCO
Contrast-enhanced CT scan - modality of choice X-ray may be initially given (widening mediastinum and pleural effusion) Superior vena cavogram (gold standard)
27
Causative organism of fibrosing mediastinitis
Histoplasmosis infection | Can cause SVCO
28
What is the most common cause of malignant hypercalcaemia?
Tumour release of PTH-related peptide
29
What mediastinal involvement might you see in lung carcinoma
Pancoast tumour: Brachial plexus compression --> shoulder or arm pain, weakness and atrophy Horner's syndrome Pleural effusion: dyspnoea and chest pain Pericardial effusion SVCO
30
What are the features of paraneoplastic syndrome?
Small Cell: Ectopic cushing's - increase in cortisol release from adrenal glands SIADH: ADH release leading to water retention Squamous cell: PTH-rh leading to hypercalcaemia Hypertrophic pulmonary osteoarthropathy (HPOA) --> clubbing and periosteal proliferation of tubular bone Hyperthyroidism Adenocarcinoma: HPOA Gynaecomastia HPOA
31
What findings might you see on CXR in a patient with lung cancer?
``` Hilam enlargement Pleural effusion Lung collapse Rib lesions Pulmonary opacity (tumour) ```
32
Lung cancer investigations
CXR CT Staging: Bronchoscopy (primary tumour visualised and sample taken) CT-guided fine needle biopsy (more reliable) Needle aspiration Thomococentesis (fluid from pleural cavity) PET scan for NSC - determines whether curative treatment Bloods - thrombocytosis, leukocytosis
33
Management of lung carcinoma according to staging?
Surgery for I and II Chemo (increases survival by a year) and radiotherapy for III Laser therapy and stenting (managing airway obstruction)
34
When would you refer a patient using suspected cancer pathway>
Over 40 and unexplained haemoptysis CXR findings suggestive of lung cancer
35
When would you offer a patient CXR within 2 weeks?
Over 40 and two of the following or smoked before and one of the following: ``` Cough Fatigue SOB Weight loss Chest pain Appetite loss ``` ``` CONSIDER if: Lymphadenopathy Clubbing Thrombocytosis Chest signs consistent with lung cancer Recurrent chest infections ```
36
Which lung cancers are not related to smoking?
Adenocarcinoma and alveolar cell carcinoma +++sputum
37
What are the features of the three types of non-small cell carcinoma?
``` Squamous cell: Central PTH-rP secretion Clubbing HPOA ``` Adenocarcinoma: Peripheral Non-smokers Large cell: Peripheral Anaplastic, poorly differentiated, poor prognosis Beta hCG production
38
What features is small cell carcinoma associated with?
ADH --> hyponatraemia ACTH --> Cushing's, adrenal hyperplasia and hypokalaemic acidosis Lambert-Eaton myasthenic syndrome
39
What might cause a false positive PSA?
Prostatitis UTI BPH Vigorous DRE
40
What % of free:total PSA suggests cancer?
<20% --> biopsy advised
41
What nodes are most likely to be affected by prostate cancer spread?
Obturator nodes
42
Management of localised (T1/T2) prostate cancer?
Watchful waiting: elderly, co-morbidities, low Gleason score Surgical: prostatectomy and obturator node excision. Risk of ED Radiotherapy: risk of rectal malignancy and radiation proctatitis. Use of brachytherapy. Potentially curative Active surveillance: T1c, Gleason 3+3, PSA <0.15, cancer in less than 50% of biopsy cores
43
Management of localised advanced (T3/T4) prostate cancer?
hormonal therapy radical prostatectomy: risk of ED radiotherapy: external beam and brachytherapy. risk of bladder, colon, and rectal cancer
44
Management of metastatic prostate cancer?
Hormonal therapy: Synthetic GnRH agonist e.g. Goserelin (Zoladex) cover initially with anti-androgen to prevent rise in testosterone Anti-androgen cyproterone acetate Orchidectomy
45
Preferred treatment for cancer associated thrombosis?
Dalteparin
46
Management of brain mets
Dexamethason (8g) PPI to protect stomach Anti-emetics
47
What three conditions are associated with bone sclerosis (increased density)
Metastatic prostate and breast carcinoma | Sickle cell disease
48
Which cancers commonly cause bony tumour deposits
``` Myeloma Melanoma Thyroid Renal Prostate Lung Breast ```